# Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study

> **NCT02457351** · PHASE1 · COMPLETED · sponsor: **Bayer** · enrollment: 14 (actual)

## Conditions studied

- Medical Oncology

## Interventions

- **DRUG:** Roniciclib (BAY 1000394)
- **DRUG:** Itraconazole (Sporanox)

## Key facts

- **NCT ID:** NCT02457351
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-02
- **Final completion:** 2016-04
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02457351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02457351, "Roniciclib (BAY 1000394) Drug-Drug Interaction (DDI) Study". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02457351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*